Previous studies have identified NPTX1 as an epigenetic target and showed that it acted as a methylation marker in human pancreatic cancer [27], and consistent results were also have been found in cervical cancer [28] and colorectal cancer [29]. Here, NPTX1 is linked to cervical carcinoma.